Hypersensitivity is an exaggerated response by the immune system to a drug or other substance.
Marijuana can help reduce the pressure inside the eye (IOP, or intraocular pressure). Being a euphoric drug, it is now a commonly used recreational and medicinal drug. In fact, its use ranks fourth among all substances, behind tobacco, alcohol and caffeine.
Atypical eating behaviors may be a sign a child should be screened for autism, according to a new study from Penn State College of Medicine.
The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes.
Proteasome inhibitors have significant promise as components of novel combination therapies to treat multidrug-resistant malaria, according to a study published June 6 in the open-access journal PLOS Pathogens by David Fidock, Caroline Ng, and Barbara Stokes of Columbia University Irving Medical Center, Matthew Bogyo of Stanford University School of Medicine, and colleagues.
More than 1 in 10 people with a range of non-cancerous lung diseases may be sick as a result of inhaling vapors, gas, dust or fumes at work, according to a joint American Thoracic Society and the European Respiratory Society statement published in the ATS’s American Journal of Respiratory and Critical Care Medicine.
Multiple sclerosis is an autoimmune disease that damages the insulating sheaths of nerve cells of the central nervous system. People with the disease can lose vision, suffer weak limbs, show degenerative symptoms and exhibit impaired cognition.
The more abnormalities in intestinal and brain function that IBS sufferers have, the more severe their symptoms of this functional bowel disorder, and the more adversely their everyday life is affected.
The U.S. Food and Drug Administration today approved Benlysta (belimumab) intravenous infusion for treatment of children with systemic lupus erythematosus – often referred to as simply "lupus" – a serious chronic disease that causes inflammation and damage to various body tissues and organs.
A research group at Hiroshima University observed a potential new target for chronic pain treatment. Further research using this receptor could lead to new, more effective drugs to use in pain-relieving treatment for chronic pain.
January 18, 2018, ACROBiosystems officially opened its New Innovation laboratory in the Delaware Innovation Space in Wilmington, Delaware, USA, and held a grand opening ceremony.
The neural 'time windows' in certain small brain areas contribute to the complex cognitive symptoms of autism, new research suggests.
In animal models of a totally crushed peripheral nerve, the damaged axons are broken down, allowing healthy ones to regrow.
It is a common health problem that causes uncommon personal discomfort. Fecal incontinence, or accidental stool leakage, affects some 8 to 10 percent of the 325 million people in the United States. In up to half of patients, there is both fecal and urinary incontinence.
A detailed study of four mouse models of autism challenges the most common assumption about what goes wrong in brain circuits to cause disease symptoms.
New research shows that a simple non-invasive hearing test early in life could predict the diagnosis of autism. The results of this study, titled 'Structural and Functional Aberrations of the Auditory Brainstem in Autism Spectrum Disorder', is published in the latest issue of the The Journal of the American Osteopathic Association (JAOA).
A noninvasive hearing test may assist with early detection and diagnosis of autism spectrum disorders, according to research published in the Journal of the American Osteopathic Association.
Research suggests that celiac disease could be caused by a bacterial enzyme used to manufacture sausages, cheese, bread and other processed foods.
A novel way in which the inflammatory response to pain is regulated has been described in the open-access journal eLife.
The holiday season is a hard one for anyone watching their weight. The sights and smells of food are hard to resist.
The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.